Chembio Diagnostics, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
NEW YORK,
Feb. 6, 2012 /PRNewswire/ -- Chembio Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, today announced that their
February 2nd RetailInvestorConferences.com presentation is now available for on-demand viewing.
LINK: www.retailinvestorconferences.com > Click the red "register/ watch event now" button.
Chembio Diagnostics, Inc.'s presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.
About Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. (OTCQB: CEMI), a profitable microcap company, develops, manufactures, licenses and markets point-of-care (POC) diagnostic tests for the detection of infectious diseases in humans and animals. Chembio's patented Dual Path Platform (DPP®) enables improved accuracy, multiplexing, and greater sample control. Several new tests have already been developed. A 3,000 patient clinical trial for an oral fluid HIV test is nearly complete and FDA approval is anticipated in late 2012 or early 2013. Chembio has collaborations with Alere Inc. (ALR), Bio-Rad Laboratories, Inc. (BIO), and the Oswaldo Cruz Foundation (FIOCRUZ), Brazil's preeminent public health institute through which five DPP® products were approved in 2010-2011, and which are now providing significant new product revenue streams to Chembio. During the 3rd quarter of 2011, revenues were $5.9 million and net income exceeded $.5 million. There are 69.6 million fully diluted shares, of which 12.4 million are held by management.
About RetailInvestorConferences.com:
Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.
SOURCE Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc., Susan Norcott, +1-631-924-1135 x125, snorcott@chembio.com; or RetailInvestorConferences.com, Bradley H. Smith, +1-201-942-7157, bradley.smith@prnewswire.com
Print Page